Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Leukemia, Myeloid, Acute 67Leukemia 28Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Lymphoma 20Lymphoma, Follicular 14Congenital Abnormalities 14Lymphoma, Non-Hodgkin 13Recurrence 12Lymphoma, Large B-Cell, Diffuse 12Leukemia, Monocytic, Acute 12Myelodysplastic Syndromes 11Leukemia, Lymphocytic, Chronic, B-Cell 9Leukemia, Erythroblastic, Acute 9Prostatic Neoplasms 8Lymphoma, Large-Cell, Immunoblastic 8Leukemia, Myelomonocytic, Acute 8Leukemia, Megakaryoblastic, Acute 8Leukemia, Biphenotypic, Acute 8Lymphoma, Mantle-Cell 7Hodgkin Disease 5Burkitt Lymphoma 5Blast Crisis 5Lymphoma, B-Cell, Marginal Zone 3Leukemia, Promyelocytic, Acute 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Sarcoma, Myeloid 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Neoplasms 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2

Interventions

Pemetrexed 22Cisplatin 20Nivolumab 8Gemcitabine 7Carboplatin 7durvalumab 5Ipilimumab 5Bevacizumab 5pembrolizumab 4Radiotherapy, Intensity-Modulated 4tremelimumab 3niraparib 3Oxaliplatin 3Drug Therapy 3Cyclophosphamide 3Cerebral Decortication 3Blood Specimen Collection 3sargramostim 2Thoracoscopy 2Surveys and Questionnaires 2Sorafenib 2Radiosurgery 2Magnesium Sulfate 2Leucovorin 2Imatinib Mesylate 2Hyperthermic Intraperitoneal Chemotherapy 2Doxorubicin 2Dexamethasone 2tislelizumab 1spartalizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Mesothelioma × Mitoxantrone × Clear all
NCT02467426 2015-06-10

Isolated Thoracic Perfusion (ITP-F) for MPM

Medias Klinikum for Surgical Oncology

Completed
23 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡